Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Human Vaccines|September 24, 2011
Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adultsFrancisco Hernández-Bernal, Arístides Aguilar-Betancourt, Virginia Aljovin, et al.
Lancet Regional Health. Americas|January 3, 2023
Correction to "Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study" [The Lancet Regional Health - Americas 2022; 16: 100366] https://doi.org/10.1016/j.lana.2022.100366Pedro I Más-Bermejo, Félix O Dickinson-Meneses, Kenia Almenares-Rodríguez, et al.
Lancet Regional Health. Americas|October 3, 2022
Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort studyPedro I Más-Bermejo, Félix O Dickinson-Meneses, Kenia Almenares-Rodríguez, et al.
Frontiers in Neurology|April 19, 2024
Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trialFrancisco Hernández-Bernal, Donner Estenoz-García, Juan H Gutiérrez-Ronquillo, et al.
International Journal of Cancer|October 16, 2025
HEBERSaVax immunotherapy combined with first-line chemotherapy in advanced ovarian cancer: Phase II CENTAURO-4 trial resultsFrancisco Hernández-Bernal, Katty-Hind Selman-Housein Bernal, Monica Bequet-Romero, et al.
Vaccine|August 16, 2024
Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE)Francisco Hernández-Bernal, Enrique Noa-Romero, Joel Quintana-Guerra, et al.
Euroasian Journal of Hepato-Gastroenterology|November 17, 2021
HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure ProphylaxisYoel A Fleites, Jorge Aguiar, Zurina Cinza, et al.
Human Vaccines|April 29, 2008
Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adultsArístides Aguilar-Betancourt, Carlos Alberto González-Delgado, Z Cinza-Estévez, et al.
Eclinicalmedicine|August 31, 2023
Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study)Zurina Cinza-Estévez, Sonia Resik-Aguirre, Nelvis L Figueroa-Baile, et al.
BMC Pregnancy and Childbirth|June 25, 2026
Assessment of safety and immunogenicity of a protein subunit COVID-19 vaccine (ABDALA) in pregnant women: a single-cohort, multicenter, observational ESPIRTA studyJorge Antonio Aguilar Estrada, Idania Baladrón Castrillo, Ivan Campa Legrá, et al.
Pageof 4